by Combat Cancer | Sep 16, 2024 | News
A recent study published in European Urology Oncology (Liedberg et al., August 13, 2024) has found that prescribed treatments for urinary tract infections (UTIs) are associated with an increased risk of delayed diagnosis of advanced bladder cancer. This comprehensive...
by Combat Cancer | Sep 6, 2024 | News
Did you know that: 1 in 2 people will experience a urological condition in their lifetime? Every year, over 78,000 people in the UK are diagnosed with urological cancers? 54% of bladder cancer patients were unaware of the signs and symptoms before diagnosis? Urology...
by Combat Cancer | Aug 30, 2024 | News
Ovarian cancer remains one of the most challenging cancers to diagnose and treat, and it has been dubbed the “silent killer” due to its subtle and often overlooked symptoms. High-grade serous ovarian cancer (HGSOC) is the most aggressive form, and...
by Combat Cancer | Aug 24, 2024 | News
Pancreatic adenocarcinoma is one of the most lethal forms of cancer. Its incidence is on the rise and, in many regions, it is predicted to become the second leading cause of cancer death in the coming decades. Unlike many other cancers, which have seen improvements in...
by Combat Cancer | Aug 16, 2024 | News
Bladder cancer is a formidable adversary, affecting thousands of people worldwide every year. In particular, patients with BCG-unresponsive bladder cancer face daunting treatment challenges. Historically, radical cystectomy has been the mainstay treatment when...
by Combat Cancer | Aug 10, 2024 | News
A recent systematic review and meta-analysis conducted by Rose et al., under the Société Internationale d’Urologie in 2022, investigated the efficacy of different interventions in recent trials that specifically included patients meeting the FDA’s...
Recent Comments